Why Every Pharmacist Should Take Note of the CVS/Aetna Deal

Perry Cohen, CEO of The Pharmacy Group, told Drug Topics that the deal should be thought of as more of horizontal integration than a vertical one. Because CVS would be able to influence Aetna's network composition, it would lead to a narrower network. CVS could mandate that Aetna customers use...

Full description

Saved in:
Bibliographic Details
Published in:Drug Topics 2017-11, Vol.161 (11), p.8-8
Main Author: Hamm, Nicholas
Format: Magazinearticle
Language:English
Subjects:
Consumers
Drug stores
Drugstores
Horizontal integration
Insurance industry
Mergers, acquisitions and divestments
Pharmacists
Pharmacy
Pharmacy benefit management
Planning
Prescription drugs
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 8
container_issue 11
container_start_page 8
container_title Drug Topics
container_volume 161
creator Hamm, Nicholas
description Perry Cohen, CEO of The Pharmacy Group, told Drug Topics that the deal should be thought of as more of horizontal integration than a vertical one. Because CVS would be able to influence Aetna's network composition, it would lead to a narrower network. CVS could mandate that Aetna customers use prefer or use only CVS pharmacies and then charge what it likes for prescription drugs because the PBM sets the price, which will hurt consumers and plan sponsors.
format magazinearticle
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_reports_1969896202</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A519252830</galeid><sourcerecordid>A519252830</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1632-a3e8b9eaaa820ccdf018d1ecebb4c6df03627f0846c2cd849587e22762dc9b93</originalsourceid><addsrcrecordid>eNpt0N9LwzAQB_AgCs7p_xAUfKsmaZsm-DTm_AFDhQ19LNf0ulbbZiaZsP_ewnyYMO7huOPzvYc7IiOu4yxSPM2OyYgxLiIpuTwlZ95_MsYSmWYjcvdRb-nsB92WvtXgOjCND3RR201b0iV8IX2xAamtaKiRTt8XtxMMPdB7hPacnFTQerz462OyfJgtp0_R_PXxeTqZRysuYxFBjKrQCABKMGPKinFVcjRYFImRwxhLkVVMJdIIU6pEpypDITIpSqMLHY_J5e7s2tnvDfqQO1xbF3zOtdRKS8HEgK52aAUt5k1f2eDAdI03-STlWqRCxWxQ0QG1wh4dtLbHqhnW__zNAT9UiV1jDgau9wL18KRQe9tuQmN7vw9_Ad62eiM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>magazinearticle</recordtype><pqid>1969896202</pqid></control><display><type>magazinearticle</type><title>Why Every Pharmacist Should Take Note of the CVS/Aetna Deal</title><source>EBSCOhost Business Source Ultimate</source><source>ABI/INFORM Global</source><creator>Hamm, Nicholas</creator><creatorcontrib>Hamm, Nicholas</creatorcontrib><description>Perry Cohen, CEO of The Pharmacy Group, told Drug Topics that the deal should be thought of as more of horizontal integration than a vertical one. Because CVS would be able to influence Aetna's network composition, it would lead to a narrower network. CVS could mandate that Aetna customers use prefer or use only CVS pharmacies and then charge what it likes for prescription drugs because the PBM sets the price, which will hurt consumers and plan sponsors.</description><identifier>ISSN: 0012-6616</identifier><identifier>EISSN: 1937-8157</identifier><language>eng</language><publisher>Monmouth Junction: UBM LLC</publisher><subject>Consumers ; Drug stores ; Drugstores ; Horizontal integration ; Insurance industry ; Mergers, acquisitions and divestments ; Pharmacists ; Pharmacy ; Pharmacy benefit management ; Planning ; Prescription drugs</subject><ispartof>Drug Topics, 2017-11, Vol.161 (11), p.8-8</ispartof><rights>COPYRIGHT 2017 UBM LLC</rights><rights>Copyright UBM Americas Nov 2017</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1969896202?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>312,776,780,787,15296,36041,44342</link.rule.ids></links><search><creatorcontrib>Hamm, Nicholas</creatorcontrib><title>Why Every Pharmacist Should Take Note of the CVS/Aetna Deal</title><title>Drug Topics</title><description>Perry Cohen, CEO of The Pharmacy Group, told Drug Topics that the deal should be thought of as more of horizontal integration than a vertical one. Because CVS would be able to influence Aetna's network composition, it would lead to a narrower network. CVS could mandate that Aetna customers use prefer or use only CVS pharmacies and then charge what it likes for prescription drugs because the PBM sets the price, which will hurt consumers and plan sponsors.</description><subject>Consumers</subject><subject>Drug stores</subject><subject>Drugstores</subject><subject>Horizontal integration</subject><subject>Insurance industry</subject><subject>Mergers, acquisitions and divestments</subject><subject>Pharmacists</subject><subject>Pharmacy</subject><subject>Pharmacy benefit management</subject><subject>Planning</subject><subject>Prescription drugs</subject><issn>0012-6616</issn><issn>1937-8157</issn><fulltext>true</fulltext><rsrctype>magazinearticle</rsrctype><creationdate>2017</creationdate><recordtype>magazinearticle</recordtype><sourceid>M0C</sourceid><recordid>eNpt0N9LwzAQB_AgCs7p_xAUfKsmaZsm-DTm_AFDhQ19LNf0ulbbZiaZsP_ewnyYMO7huOPzvYc7IiOu4yxSPM2OyYgxLiIpuTwlZ95_MsYSmWYjcvdRb-nsB92WvtXgOjCND3RR201b0iV8IX2xAamtaKiRTt8XtxMMPdB7hPacnFTQerz462OyfJgtp0_R_PXxeTqZRysuYxFBjKrQCABKMGPKinFVcjRYFImRwxhLkVVMJdIIU6pEpypDITIpSqMLHY_J5e7s2tnvDfqQO1xbF3zOtdRKS8HEgK52aAUt5k1f2eDAdI03-STlWqRCxWxQ0QG1wh4dtLbHqhnW__zNAT9UiV1jDgau9wL18KRQe9tuQmN7vw9_Ad62eiM</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Hamm, Nicholas</creator><general>UBM LLC</general><general>MultiMedia Healthcare Inc</general><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7RQ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>883</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0F</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>U9A</scope></search><sort><creationdate>20171101</creationdate><title>Why Every Pharmacist Should Take Note of the CVS/Aetna Deal</title><author>Hamm, Nicholas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1632-a3e8b9eaaa820ccdf018d1ecebb4c6df03627f0846c2cd849587e22762dc9b93</frbrgroupid><rsrctype>magazinearticle</rsrctype><prefilter>magazinearticle</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Consumers</topic><topic>Drug stores</topic><topic>Drugstores</topic><topic>Horizontal integration</topic><topic>Insurance industry</topic><topic>Mergers, acquisitions and divestments</topic><topic>Pharmacists</topic><topic>Pharmacy</topic><topic>Pharmacy benefit management</topic><topic>Planning</topic><topic>Prescription drugs</topic><toplevel>online_resources</toplevel><creatorcontrib>Hamm, Nicholas</creatorcontrib><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Career &amp; Technical Education Database</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>ABI/INFORM Trade &amp; Industry (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>ABI/INFORM Trade &amp; Industry</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Drug Topics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamm, Nicholas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Why Every Pharmacist Should Take Note of the CVS/Aetna Deal</atitle><jtitle>Drug Topics</jtitle><date>2017-11-01</date><risdate>2017</risdate><volume>161</volume><issue>11</issue><spage>8</spage><epage>8</epage><pages>8-8</pages><issn>0012-6616</issn><eissn>1937-8157</eissn><abstract>Perry Cohen, CEO of The Pharmacy Group, told Drug Topics that the deal should be thought of as more of horizontal integration than a vertical one. Because CVS would be able to influence Aetna's network composition, it would lead to a narrower network. CVS could mandate that Aetna customers use prefer or use only CVS pharmacies and then charge what it likes for prescription drugs because the PBM sets the price, which will hurt consumers and plan sponsors.</abstract><cop>Monmouth Junction</cop><pub>UBM LLC</pub><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-6616
ispartof Drug Topics, 2017-11, Vol.161 (11), p.8-8
issn 0012-6616
1937-8157
language eng
recordid cdi_proquest_reports_1969896202
source EBSCOhost Business Source Ultimate; ABI/INFORM Global
subjects Consumers
Drug stores
Drugstores
Horizontal integration
Insurance industry
Mergers, acquisitions and divestments
Pharmacists
Pharmacy
Pharmacy benefit management
Planning
Prescription drugs
title Why Every Pharmacist Should Take Note of the CVS/Aetna Deal
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A46%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Why%20Every%20Pharmacist%20Should%20Take%20Note%20of%20the%20CVS/Aetna%20Deal&rft.jtitle=Drug%20Topics&rft.au=Hamm,%20Nicholas&rft.date=2017-11-01&rft.volume=161&rft.issue=11&rft.spage=8&rft.epage=8&rft.pages=8-8&rft.issn=0012-6616&rft.eissn=1937-8157&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA519252830%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g1632-a3e8b9eaaa820ccdf018d1ecebb4c6df03627f0846c2cd849587e22762dc9b93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1969896202&rft_id=info:pmid/&rft_galeid=A519252830&rfr_iscdi=true